Companies / Kymera Therapeutics, Inc. / Activity
Activity — Kymera Therapeutics, Inc.
62 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 11, 2026 | Chadwick Jeremy G Executive | Sell | Common Stock | $930.2K | -11K -14.04% | 68,052 0.08% of shares | medium |
| Mar 11, 2026 | Chadwick Jeremy G Executive | Sell | Common Stock | $1.07M | -13K -14.00% | 79,163 0.10% of shares | medium |
| Apr 1, 2026 | Chadwick Jeremy G Executive | Sell | Common Stock | $1.16M | -14K -17.85% | 62,302 0.07% of shares | medium |
| Mar 23, 2026 | Chadwick Jeremy G Executive | Sell | Common Stock | $1.75M | -23K -14.93% | 129,696 0.16% of shares | medium |
| Feb 25, 2026 | Mainolfi Nello CEO | Sell | Common Stock | $1.77M | -20K -2.84% | 676,431 0.81% of shares | medium |
| Mar 25, 2026 | Chadwick Jeremy G Executive | Sell | Common Stock | $1.98M | -25K -28.78% | 61,202 0.07% of shares | medium |
| Mar 23, 2026 | Chadwick Jeremy G Executive | Sell | Common Stock | $4.09M | -53K -40.85% | 76,721 0.09% of shares | medium |
| Jun 26, 2026 | Bvf Partners L P/IL Director | Sell | Common Stock, $0.0001 par value | $5.52M | -52K -39.69% | 78,787 0.09% of shares | medium |
| Mar 2, 2026 | Booth Bruce Director | Sell | Common Stock | $6.47M | -72K -1.81% | 3,902,667 4.69% of shares | medium |
| Jun 26, 2026 | Bvf Partners L P/IL Director | Sell | Common Stock, $0.0001 par value | $12.07M | -113K -32.06% | 240,123 0.29% of shares | high |
| Jun 26, 2026 | Bvf Partners L P/IL Director | Sell | Common Stock, $0.0001 par value | $66.84M | -628K -28.27% | 1,592,261 1.91% of shares | high |
| Jun 26, 2026 | Bvf Partners L P/IL Director | Sell | Common Stock, $0.0001 par value | $89.24M | -838K -29.94% | 1,960,881 2.36% of shares | high |